GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: CDP 6038 | CDP-6038 | CDP6038
                                 
                                                         
                            Compound class: 
                                                            Antibody
                                 
                                
                                    
                                        Comment: Olokizumab (CDP 6038) is a clinical stage anti-IL-6 monoclonal antibody [3], that was designed for potential to treat autoimmune diseases. The antibody blocks assembly of the hexameric IL-6/IL-6 α-receptor/gp130 (IL6ST) complex that is required for signal transduction.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
Classification ![]()  | 
                                                    |
| Compound class | Antibody | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 9333 | olokizumab | 
Synonyms ![]()  | 
                                                        
| CDP 6038 | CDP-6038 | CDP6038 | 
Database Links ![]()  | 
                                                        |
| Specialist databases | |
| IMGT/mAb-DB | 353 | 
| Other databases | |
| GtoPdb PubChem SID | 442878635 | 
| Search PubMed clinical trials | olokizumab | 
| Search PubMed titles | olokizumab | 
| Search PubMed titles/abstracts | olokizumab |